Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial-Reference-Cited by-同舟云学术

Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

Published:2020-12-02 Issue:2 Volume:134 Page:185-192
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Ge Jun-Bo,Fan Wei-Hu,Zhou Jing-Min,Shi Hai-Ming,Ji Fu-Sui,Wu Yang,Zhao Yu-Lan,Qian Jun,Jin Yuan-Zhe,Liu Ying-Wu,Wang Sheng-Huang,He Sheng-Hu,Yang Ping,Wu Jie,Lu Feng,Hou Zi-Shan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference36 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

2. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the american heart association and american college of cardiology foundation;Smith;Circulation,2011

3. 2016 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult;Anderson;Can J Cardiol,2016

4. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR);Piepoli;Eur Heart J,2016

5. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis;Bhatt;JAMA,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based prediction of composite risk of cardiovascular events in patients with stable angina pectoris combined with coronary heart disease: development and validation of a clinical prediction model for Chinese patients;Frontiers in Pharmacology;2024-01-10

2. Potential Effects of Traditional Chinese Medicine on COVID-19 and Cardiac Injury: Mechanisms and Clinical Evidence;Journal of Multidisciplinary Healthcare;2023-09

3. Shexiang Baoxin Pill treats acute myocardial infarction by promoting angiogenesis via GDF15-TRPV4 signaling;Biomedicine & Pharmacotherapy;2023-09

4. Identifying coronary artery bypass grafting patients at high risk for adverse long-term prognosis using serial health-related quality of life assessments;Chinese Medical Journal;2023-08-24

5. Single-nucleus ribonucleic acid-sequencing and spatial transcriptomics reveal the cardioprotection of Shexiang Baoxin Pill (SBP) in mice with myocardial ischemia-reperfusion injury;Frontiers in Pharmacology;2023-05-09